Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders.

Céline LouapreMichella IbrahimElisabeth MaillartBasma AbdiCaroline PapeixBruno StankoffAnne-Laure DubessyCaroline Bensa-KoscherAlain CréangeZina ChamekhCatherine LubetzkiAnne-Geneviève MarcelinJean-Christophe CorvolValérie Pourchernull null

Published in: Journal of neurology, neurosurgery, and psychiatry (2021)

NCT04568707.

Keyphrases

immune response
sars cov
respiratory syndrome coronavirus
dendritic cells
toll like receptor
nk cells
inflammatory response